← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 31, 2018Last known activity
Oct 29, 2024
Timeline
2010s
- Jan 1, 2016
COMPASS Pathways— Founded
Drugs by trial phase (1 distinct, 14 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT06247839CollaboratorPhase 3Oct 29, 2024
- NCT05711940Lead sponsorPhase 3Feb 14, 2023
- NCT05733546Lead sponsorPhase 2Jan 30, 2023
- NCT05624268Lead sponsorPhase 3Nov 30, 2022
- NCT05481736Lead sponsorPhase 2Oct 12, 2022
- NCT05381974CollaboratorPhase 2Sep 15, 2022
- NCT05312151Lead sponsorPhase 2Jul 31, 2022
- NCT05220410CollaboratorPhase 2Mar 28, 2022
- NCT04656301CollaboratorPhase 2Jan 31, 2021
- NCT04661514CollaboratorPhase 2Dec 15, 2020
- NCT04739865Lead sponsorPhase 2Sep 15, 2020
- NCT04433858CollaboratorPhase 2Jul 12, 2020
- NCT04433845CollaboratorPhase 2Jul 12, 2020
- NCT03775200Lead sponsorPhase 2Dec 31, 2018
Details
- Founded
- London, GB Jan 1, 2016
- Last known activity
- Oct 29, 2024